Current Trends in GLP-1 Usage Among Americans
TL;DR Summary
Over 2% of Americans are now taking GLP-1 drugs for weight loss or diabetes, marking a nearly 600% increase over six years, with the majority using drugs like Ozempic and Mounjaro; however, most patients with overweight or obesity are still not receiving these treatments or bariatric surgery.
Reading Insights
Total Reads
0
Unique Readers
7
Time Saved
1 min
vs 1 min read
Condensed
76%
193 → 47 words
Want the full story? Read the original article
Read on Axios